A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ke,Hu

第一单位： Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China. huke-rmhospital@163.com.

作者： Ke,Hu ^[1] ; Mengmei,Wang ^[2] ; Yang,Zhao ^[2] ; Yunting,Zhang ^[2] ; Tao,Wang ^[2] ; Zhishui,Zheng ^[2] ; Xiaochen,Li ^[2] ; Shaolin,Zeng ^[2] ; Dong,Zhao ^[2] ; Honglin,Li ^[3] ; Ke,Xu ^[4] ; Ke,Lan ^[5]

作者单位： Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China. huke-rmhospital@163.com. ^[1] Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ^[2] Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China. hlli@ecust.edu.cn. ^[3] State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China. xuke03@whu.edu.cn. ^[4] State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China. klan@whu.edu.cn.;Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, 430072, China. klan@whu.edu.cn. ^[5]

关键词 Coronavirus disease 2019 (COVID-19)DHODH inhibitors Inflammation Leflunomide Viral shedding time

主题词老年人(Aged);抗病毒药(Antiviral Agents);C反应蛋白质(C-Reactive Protein);中国(China);女(雌)性(Female);人类(Humans);肺(Lung);男(雄)性(Male);中年人(Middle Aged);病毒复制(Virus Replication);病毒脱落(Virus Shedding)

DOI 10.1007/s12250-020-00258-7

PMID 32696396

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Virologica Sinica

2020年35卷6期

725-733页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.

Virologica Sinica

相似文献

Virologica Sinica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.

Virologica Sinica

相似文献

Virologica Sinica

相关期刊

检索历史清除